Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Enabling remote monitoring of lung health, Strados Labs’ RESP Biosensor allows clinicians to continuously measure patients’ lung sounds such as cough and wheeze that can indicate an exacerbation or reduced quality of life. The technology is used to assist drug developers in demonstrating treatment efficacy in clinical trials and to support clinicians in disease surveillance and management. The RESP Biosensor is FDA-cleared, CE marked and HIPAA compliant, backed by multiple awards and clinical publications. Strados Labs is privately owned and based in Philadelphia, PA.
Society for Advanced Bronchoscopy
The Society for Advanced Bronchoscopy (SAB) is an international organization of health care professionals committed to improving health through the study, prevention, diagnosis, and management of advanced bronchoscopy techniques. Our mission is to promote and support excellence in interpretive skills and technical knowledge of those involved in advanced bronchoscopy and to help maintain professional practice integrity.
Regeneron and Sanofi
Regeneron and Sanofi collaborate to jointly develop certain fully-human monoclonal antibody therapies under a global collaboration agreement. Regeneron is a leading biotechnology company that that invents life-transforming medicines for serious diseases. Sanofi is a global biopharmaceutical company focused on human health. For more information, visit www.Regeneron.com and www.Sanofi.com.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.